Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 224 articles:
HTML format



Single Articles


    November 2021
  1. DOU D, Ji Y, Zheng J, Li J, et al
    A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4(+)T Cells into Th1 Cells.
    Dig Dis Sci. 2021 Nov 9. pii: 10.1007/s10620-021-07300.
    PubMed     Abstract available


  2. LU J, Liu D, Tan Y, Li R, et al
    Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
    Dig Dis Sci. 2021;66:3803-3812.
    PubMed     Abstract available


  3. HONG SJ, Jang J, Berg D, Kirat T, et al
    Implementation of an Inpatient IBD Service Is Associated with Improvement in Quality of Care and Long-Term Outcomes.
    Dig Dis Sci. 2021;66:3753-3759.
    PubMed     Abstract available


    October 2021
  4. XU F, Carlson SA, Liu Y, Greenlund KJ, et al
    Urban-Rural Differences in Health Care Utilization for Inflammatory Bowel Disease in the USA, 2017.
    Dig Dis Sci. 2021 Oct 11. pii: 10.1007/s10620-021-07264.
    PubMed     Abstract available


  5. RABINOWITZ LG, Zylberberg HM, Yang J, Gold SL, et al
    De Novo Ostomy Placement Is Associated with Increased Outpatient Opioid Use In Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Oct 6. pii: 10.1007/s10620-021-07257.
    PubMed     Abstract available


  6. RAKOWSKY ST, Feuerstein JD
    Highs and Lows of Proactive Therapeutic Drug Monitoring in Crohn's Patients.
    Dig Dis Sci. 2021;66:3226-3227.
    PubMed    


  7. LUO Y, Cheng Q, Fang Y, Yu J, et al
    Infliximab Therapy in Very Early Onset Crohn's Disease: Real-World Experience in China.
    Dig Dis Sci. 2021;66:3555-3562.
    PubMed     Abstract available


  8. ZHANG J, Li Y, Diao Y, Da B, et al
    Long-Term Outcome of Endoscopic Balloon Dilation for Duodenal Crohn's Disease-Associated Strictures.
    Dig Dis Sci. 2021;66:3570-3577.
    PubMed     Abstract available


  9. YARUR AJ, Deepak P, Vande Casteele N, Battat R, et al
    Association Between Vedolizumab Levels, Anti-vedolizumab Antibodies, and Endoscopic Healing Index in a Large Population of Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:3563-3569.
    PubMed     Abstract available


  10. BORREN NZ, Paulides E, Frinack JL, Olson RN, et al
    Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study.
    Dig Dis Sci. 2021;66:3548-3554.
    PubMed     Abstract available


    September 2021
  11. SELINGER CP, Rafferty H, Mooney P, Donnellan C, et al
    Utility of Fecal Calprotectin in Routine Clinical Practice Is Impaired by Poor Sample Return Rates.
    Dig Dis Sci. 2021;66:3209-3210.
    PubMed    


  12. JEON Y, Limketkai BN
    Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD.
    Dig Dis Sci. 2021;66:2853-2854.
    PubMed    


  13. DE SA BRITO FROES R, da Luz Moreira A, Carneiro AJV, Moreira JPL, et al
    Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
    Dig Dis Sci. 2021;66:2925-2934.
    PubMed     Abstract available


  14. ZHANG B, Su X, Xie Z, Ding H, et al
    Inositol-Requiring Kinase 1 Regulates Apoptosis via Inducing Endoplasmic Reticulum Stress in Colitis Epithelial Cells.
    Dig Dis Sci. 2021;66:3015-3025.
    PubMed     Abstract available


  15. KIM JY, Park SH, Park JC, Noh S, et al
    The Clinical Significance of Anastomotic Ulcers After Ileocolic Resection to Predict Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2021;66:3132-3140.
    PubMed     Abstract available


  16. ZEZE K, Hirano A, Torisu T, Esaki M, et al
    Adding Thiopurine After Loss of Response to Infliximab Versus Early Combination in Treating Crohn's Disease: A Retrospective Study.
    Dig Dis Sci. 2021;66:3124-3131.
    PubMed     Abstract available


  17. VARMA S, Faye AS, Kannan A, Lawlor G, et al
    Patients with More Severe IBD Get Clostridioides difficile Rather than Clostridioides difficile Increasing the Severity of IBD.
    Dig Dis Sci. 2021;66:3113-3123.
    PubMed     Abstract available


    August 2021
  18. JAMPALA N, Jain A, Herfarth HH, Long MD, et al
    Personalized Best: Toward Improving Care in Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07221.
    PubMed    


  19. SATO M, Fujii K, Takagi H, Shibuya I, et al
    Antibacterial and Immunosuppressive Effects of OPS-2071, a Candidate Therapy for Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07237.
    PubMed     Abstract available


  20. ISHIDA N, Miyazu T, Tamura S, Tani S, et al
    Real-World Efficacy and Safety Monitoring for Predicting Continuation of Tofacitinib Therapy in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Aug 30. pii: 10.1007/s10620-021-07233.
    PubMed     Abstract available


  21. KAYAL M, Bhagya Rao B, Bhattacharya A, Ungaro R, et al
    Clinical Challenge: From Ulcerative Colitis to Crohn's Disease-Like Pouch Inflammation.
    Dig Dis Sci. 2021 Aug 20. pii: 10.1007/s10620-021-07220.
    PubMed    


  22. DAI C, Jiang M, Huang YH
    COVID-19 Vaccination in Patients with Inflammatory Bowel Disease: A Survey from China.
    Dig Dis Sci. 2021 Aug 19. pii: 10.1007/s10620-021-07169.
    PubMed    


  23. GUERRERO VINSARD D, Karagozian R, Wakefield DB, Kane SV, et al
    Maternal Outcomes and Pregnancy-Related Complications Among Hospitalized Women with Inflammatory Bowel Disease: Report from the National Inpatient Sample.
    Dig Dis Sci. 2021 Aug 18. pii: 10.1007/s10620-021-07210.
    PubMed     Abstract available


  24. TSAI L, Nguyen NH, Ma C, Prokop LJ, et al
    Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Dig Dis Sci. 2021 Aug 11. pii: 10.1007/s10620-021-07200.
    PubMed     Abstract available


  25. PARRA RS, da Rocha JJR, Feres O
    Growth Delay in Inflammatory Bowel Diseases: The Importance of Surgery.
    Dig Dis Sci. 2021;66:2840-2841.
    PubMed    


  26. HOU JK
    Antibiotics for Crohn's Disease: What Are We Treating?
    Dig Dis Sci. 2021;66:2478-2480.
    PubMed    


  27. PROCTOR DD
    DDS Perspective: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2489-2492.
    PubMed    


  28. PROCTOR DD
    DDS Profile: Deborah D. Proctor, MD.
    Dig Dis Sci. 2021;66:2486-2488.
    PubMed    


  29. PAUL S, Williet N, Nancey S, Veyrard P, et al
    No Difference of Adalimumab Pharmacokinetics When Dosed at 40 mg Every Week or 80 mg Every Other Week in IBD Patients in Clinical Remission After Adalimumab Dose Intensification.
    Dig Dis Sci. 2021;66:2744-2749.
    PubMed     Abstract available


  30. ALIBAZ-ONER F, Ergelen R, Ergenc I, Seven G, et al
    Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behcet's Disease with Intestinal Involvement and Crohn's Disease.
    Dig Dis Sci. 2021;66:2750-2755.
    PubMed     Abstract available


  31. SHPOLIANSKY M, Roggenbuck D, Pinsker M, Salamon N, et al
    Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease.
    Dig Dis Sci. 2021;66:2619-2626.
    PubMed     Abstract available


  32. DA COSTA FERREIRA S, Sadissou IA, Parra RS, Feitosa MR, et al
    Increased HLA-G Expression in Tissue-Infiltrating Cells in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:2610-2618.
    PubMed     Abstract available


  33. CHATEAU T, Damico F, Zallot C, Mathieu N, et al
    Crohn's Disease Only Visible on Small Bowel Capsule Endoscopy: A New Entity.
    Dig Dis Sci. 2021;66:2712-2716.
    PubMed     Abstract available


  34. RHODES JM, Subramanian S, Flanagan PK, Horgan GW, et al
    Randomized Trial of Ciprofloxacin Doxycycline and Hydroxychloroquine Versus Budesonide in Active Crohn's Disease.
    Dig Dis Sci. 2021;66:2700-2711.
    PubMed     Abstract available


    July 2021
  35. SALWEN-DEREMER JK, Smith MT, Haskell HG, Schreyer C, et al
    Poor Sleep in Inflammatory Bowel Disease Is Reflective of Distinct Sleep Disorders.
    Dig Dis Sci. 2021 Jul 30. pii: 10.1007/s10620-021-07176.
    PubMed     Abstract available


  36. NARULA N, Hu A, Nguyen GC, Rangrej J, et al
    Periodic Colonoscopies Are Associated with Improved Survival and Prognosis of Colorectal Cancer in Ulcerative Colitis.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07151.
    PubMed     Abstract available


  37. STEWART MJ
    Does Surveillance Increase Survival? Benefits of Periodic Colonoscopy in Patients with Ulcerative Colitis and Colorectal Cancer.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07174.
    PubMed    


  38. HEATH EM, Kim RB, Wilson A
    A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jul 27. pii: 10.1007/s10620-021-07177.
    PubMed     Abstract available


  39. GOLOVICS PA, Gonczi L, Reinglas J, Verdon C, et al
    Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study.
    Dig Dis Sci. 2021 Jul 20. pii: 10.1007/s10620-021-07178.
    PubMed     Abstract available


  40. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2021 Jul 14. pii: 10.1007/s10620-021-07130.
    PubMed     Abstract available


  41. RAO S, Borum ML
    Evaluating IBD Patient-Initiated Electronic Communication During the SARS-CoV-2 Pandemic: A Single-Center Study.
    Dig Dis Sci. 2021;66:2468-2469.
    PubMed    


  42. DALAL RS, Lichtenstein GR
    Superiority Complex: Do Teaching Hospitals Provide Inferior Care for IBD Patients?
    Dig Dis Sci. 2021;66:2137-2139.
    PubMed    


  43. HUDHUD D, Zhu G, Twaddell W, Bafford A, et al
    "Sarc" Attack: Rectal Bleeding in an Elderly Patient with Small Bowel Crohn's Disease.
    Dig Dis Sci. 2021;66:2190-2193.
    PubMed    


  44. CALABRESE C, Dussias N, Impellizzeri G, Lauro A, et al
    CEing More-Assessing Small Bowel Crohn's with Capsule Endoscopy (CE).
    Dig Dis Sci. 2021;66:2173-2176.
    PubMed     Abstract available


    June 2021
  45. PAULIDES E, Pasma A, Erler NS, van Eijk RLA, et al
    Impact of the Coronavirus Disease Pandemic on Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07118.
    PubMed     Abstract available


  46. PAREKH R, Zhang X, Ungaro RC, Brenner EJ, et al
    Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 28. pii: 10.1007/s10620-021-07104.
    PubMed     Abstract available


  47. BHAT S, Limdi JK, Cross RK, Farraye FA, et al
    Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07114.
    PubMed     Abstract available


  48. GRANDMOUGIN A, D'Amico F, Remen T, Danese S, et al
    Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Jun 22. pii: 10.1007/s10620-021-07016.
    PubMed     Abstract available


  49. FAWSON S, Dibley L, Smith K, Batista J, et al
    Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.
    Dig Dis Sci. 2021 Jun 19. pii: 10.1007/s10620-021-07109.
    PubMed     Abstract available


  50. STONE ML, Feng M, Forster EM
    COVID-19 Pandemic Increased Anxiety Among Patients with Inflammatory Bowel Disease: A Patient Survey in a Tertiary Referral Center.
    Dig Dis Sci. 2021 Jun 11. pii: 10.1007/s10620-021-07095.
    PubMed     Abstract available


  51. MCCURDY JD, Ellen Kuenzig M, Spruin S, Fung OW, et al
    Surgery and the Subtype of Inflammatory Bowel Disease Impact the Risk of Venous Thromboembolism After Hospital Discharge.
    Dig Dis Sci. 2021 Jun 10. pii: 10.1007/s10620-021-07064.
    PubMed     Abstract available


  52. ISHIHARA J, Arai K, Kudo T, Nambu R, et al
    Serum Zinc and Selenium in Children with Inflammatory Bowel Disease: A Multicenter Study in Japan.
    Dig Dis Sci. 2021 Jun 8. pii: 10.1007/s10620-021-07078.
    PubMed     Abstract available


  53. JEON Y, Leung D, Lis CA, Wang HL, et al
    Casting a Wider NET: Is It Crohn's or Is It Neuroendocrine Tumor?
    Dig Dis Sci. 2021;66:1802-1806.
    PubMed    


  54. ARMSTRONG J, Sarhan S
    Observations on the Effect of Electronic Needle Container on Adherence to Adalimumab.
    Dig Dis Sci. 2021;66:2135-2136.
    PubMed    


  55. ABOUBAKR A, Riggs AR, Jimenez D, Mella MT, et al
    Identifying Patient Priorities for Preconception and Pregnancy Counseling in IBD.
    Dig Dis Sci. 2021;66:1829-1835.
    PubMed     Abstract available


    May 2021
  56. EMERSON C, Fuller-Tyszkiewicz M, Orr R, Lyall K, et al
    Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 29. pii: 10.1007/s10620-021-07065.
    PubMed     Abstract available


  57. AL KHOURY A, Balram B, Bessissow T, Afif W, et al
    Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review.
    Dig Dis Sci. 2021 May 21. pii: 10.1007/s10620-021-07025.
    PubMed     Abstract available


  58. CARON B, Neuville E, Peyrin-Biroulet L
    Inflammatory Bowel Disease and COVID-19 Vaccination: A Patients' Survey.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07040.
    PubMed     Abstract available


  59. SYED A, Seoud T, Carleton NM, Thakkar S, et al
    Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 May 4. pii: 10.1007/s10620-021-06969.
    PubMed     Abstract available


  60. JOGENDRAN R, Tandon P, Kroeker KI, Dieleman LA, et al
    A Dedicated Pregnancy Clinic Improves Reproductive Knowledge in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-06998.
    PubMed     Abstract available


  61. HAO Y, Yzet C, McBride RB, Stock A, et al
    Baseline Histological Findings Do Not Predict the Risk of Subsequent Extension in Patients with Limited Ulcerative Colitis.
    Dig Dis Sci. 2021 May 2. pii: 10.1007/s10620-021-06970.
    PubMed     Abstract available


  62. WEN T, Faye AS, Lee KE, Friedman AM, et al
    Risk of Postpartum Flare Hospitalizations in Patients with Inflammatory Bowel Disease Persists After Six Months.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06999.
    PubMed     Abstract available


  63. KOCHAR BD, Cai W, Ananthakrishnan AN
    Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty.
    Dig Dis Sci. 2021 May 1. pii: 10.1007/s10620-021-06990.
    PubMed     Abstract available


  64. HASHASH JG, Mourad FH
    Perianal Fistulizing Crohn's Disease: No Shortcuts to a Deep Understanding of the Disease.
    Dig Dis Sci. 2021;66:1392-1393.
    PubMed    


  65. JIANG ZF, Zhang L
    LncRNA: A Potential Research Direction in Intestinal Barrier Function.
    Dig Dis Sci. 2021;66:1400-1408.
    PubMed     Abstract available


  66. SCHULTHEISS JPD, Altena S, Clevers MR, Baas D, et al
    Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle Container.
    Dig Dis Sci. 2021;66:1477-1487.
    PubMed     Abstract available


  67. ZHU M, Xu X, Feng Q, Cui Z, et al
    Effectiveness of Infliximab on Deep Radiological Remission in Chinese Patients with Perianal Fistulizing Crohn's Disease.
    Dig Dis Sci. 2021;66:1658-1668.
    PubMed     Abstract available


  68. SINGH AK, Kumar R, Gupta P, Kumar-M P, et al
    FDG-PET-CT Enterography Helps Determine Clinical Significance of Suspected Ileocecal Thickening: A Prospective Study.
    Dig Dis Sci. 2021;66:1620-1630.
    PubMed     Abstract available


  69. ROLSTON VS, Kimmel J, Popov V, Bosworth BP, et al
    Ustekinumab Does Not Increase Risk of Adverse Events: A Meta-Analysis of Randomized Controlled Trials.
    Dig Dis Sci. 2021;66:1631-1638.
    PubMed     Abstract available


    April 2021
  70. DAI C, Huang YH
    Letter to the Editor on "Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease Patients During the SARS-CoV-2 Pandemic".
    Dig Dis Sci. 2021 Apr 29. pii: 10.1007/s10620-021-06957.
    PubMed    


  71. GUDINO V, Salas A
    Promise of Mesenchymal Stem Cell Lysates in IBD Therapy: Are the Parts Greater than the Whole?
    Dig Dis Sci. 2021;66:932-934.
    PubMed    


  72. WONG K, Isaac DM, Wine E
    Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management.
    Dig Dis Sci. 2021;66:954-964.
    PubMed     Abstract available


    March 2021
  73. SOO WT, Costello SP, Bryant RV
    Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 25. pii: 10.1007/s10620-021-06946.
    PubMed    


  74. BARBER GE, Hendler S, Choe M, Keyashian K, et al
    Thiopurine Monotherapy Is Effective in Maintenance of Mild-Moderate Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Mar 23. pii: 10.1007/s10620-021-06947.
    PubMed     Abstract available


  75. HONAP S, Meade S, Ibraheim H, Irving PM, et al
    Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-021-06932.
    PubMed     Abstract available


  76. BAMIAS G, Kokkotis G, Gizis M, Kapizioni C, et al
    Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort.
    Dig Dis Sci. 2021 Mar 9. pii: 10.1007/s10620-021-06907.
    PubMed     Abstract available


  77. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    PubMed     Abstract available


  78. CAI W, Cagan A, He Z, Ananthakrishnan AN, et al
    A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2021;66:760-767.
    PubMed     Abstract available


    February 2021
  79. BASIL M, Schwartz D, Dalal R, Horst S, et al
    Mucosal Integrity Testing Can Detect Differences in the Rectums of Patients with Inflammatory Bowel Disease Compared to Controls: A Pilot Study.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06888.
    PubMed     Abstract available


  80. MONTENEGRO ML, Corral JE, Lukens FJ, Ji B, et al
    Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 24. pii: 10.1007/s10620-021-06899.
    PubMed     Abstract available


  81. LUO W, Tian L, Tan B, Shen Z, et al
    Update: Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 20. pii: 10.1007/s10620-021-06831.
    PubMed     Abstract available


  82. VERMA A, Varma S, Freedberg DE, Axelrad JE, et al
    A Simple Emergency Department-Based Score Predicts Complex Hospitalization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 19. pii: 10.1007/s10620-021-06877.
    PubMed     Abstract available


  83. LLANOS-CHEA A, Shapiro JM, Winter RW, Jerger L, et al
    Lymphoma in Pediatric-Onset Inflammatory Bowel Disease Treated with Infliximab Monotherapy: A Case Series.
    Dig Dis Sci. 2021 Feb 17. pii: 10.1007/s10620-021-06884.
    PubMed     Abstract available


  84. DALAL RS, Ananthakrishnan AN, Hamilton MJ, Winter RW, et al
    Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dig Dis Sci. 2021 Feb 11. pii: 10.1007/s10620-021-06852.
    PubMed    


  85. BARSKY M, Meserve J, Le H, Collins A, et al
    Correction to: Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06879.
    PubMed    


  86. SHIRAISHI K, Furukawa S, Yagi S, Mori K, et al
    Serum Globulin Is Associated with Endoscopic Findings and Mucosal Healing in Japanese Patients with Ulcerative Colitis.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06834.
    PubMed     Abstract available


  87. JAGT JZ, Pothof CD, Buiter HJC, van Limbergen JE, et al
    Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study.
    Dig Dis Sci. 2021 Feb 3. pii: 10.1007/s10620-021-06836.
    PubMed     Abstract available


  88. QI Y, Wu HM, Yang Z, Zhou YF, et al
    New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
    Dig Dis Sci. 2021 Feb 1. pii: 10.1007/s10620-021-06837.
    PubMed     Abstract available


  89. GAIDOS JKJ, Kane SV
    Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications.
    Dig Dis Sci. 2021;66:336-337.
    PubMed    


  90. AGRAWAL G, Aitken J, Hamblin H, Collins M, et al
    Putting Crohn's on the MAP: Five Common Questions on the Contribution of Mycobacterium avium subspecies paratuberculosis to the Pathophysiology of Crohn's Disease.
    Dig Dis Sci. 2021;66:348-358.
    PubMed     Abstract available


  91. NIV E, Ovadia B, Groisman G, Kopelman Y, et al
    CMV-Induced Severe Colonic Stricture in an Adult Crohn's Disease Patient.
    Dig Dis Sci. 2021;66:636-639.
    PubMed    


    January 2021
  92. SINH P, Tabibian JH, Biyani PS, Mehta K, et al
    Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.
    Dig Dis Sci. 2021 Jan 25. pii: 10.1007/s10620-020-06818.
    PubMed     Abstract available


  93. GRAZIANO F, Macaluso FS, Cassata N, Citrano M, et al
    Rescue Therapy with Intensive Vedolizumab Optimization in a Seventeen-Year-Old Girl with Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-021-06826.
    PubMed    


  94. IBORRA I, Puig M, Marin L, Calafat M, et al
    Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic.
    Dig Dis Sci. 2021 Jan 19. pii: 10.1007/s10620-020-06807.
    PubMed     Abstract available


  95. DEL VALLE JP, Lee GC, Serrato JC, Feuerstein JD, et al
    Recurrence of Clostridium Difficile and Cytomegalovirus Infections in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-Anal Anastomosis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06772.
    PubMed     Abstract available


  96. TOWNSEND CM, Khanna R, Wilson AS
    A More Severe Non-melanoma Skin Cancer Phenotype Is Seen in Patients with Inflammatory Bowel Disease on Tumor Necrosis Factor-alpha Antagonists.
    Dig Dis Sci. 2021 Jan 11. pii: 10.1007/s10620-020-06773.
    PubMed     Abstract available


    December 2020
  97. FIORUCCI S, Carino A, Baldoni M, Santucci L, et al
    Bile Acid Signaling in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020 Dec 8. pii: 10.1007/s10620-020-06715.
    PubMed     Abstract available


  98. BORREN NZ, Tan W, Jess AT, Li PM, et al
    Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study.
    Dig Dis Sci. 2020;65:3672-3678.
    PubMed     Abstract available


  99. GAO XH, Yu GY, Khan F, Li JQ, et al
    Greater Peripouch Fat Area on CT Image Is Associated with Chronic Pouchitis and Pouch Failure in Inflammatory Bowel Diseases Patients.
    Dig Dis Sci. 2020;65:3660-3671.
    PubMed     Abstract available


  100. LUO Y, Tixier EN, Grinspan AM
    Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Dig Dis Sci. 2020;65:3647-3651.
    PubMed     Abstract available


    November 2020
  101. DULAI PS, Jairath V
    A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06707.
    PubMed     Abstract available


  102. ZHANG Y, Li X, Li Y, Li Y, et al
    DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06697.
    PubMed     Abstract available


  103. BALRAM B, Joshi H, Wong K, Kroeker KI, et al
    Concomitant 5-Aminosalicylate Therapy in Moderate-to-Severe Ulcerative Colitis Patients Escalated to Infliximab Is Not Beneficial.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06704.
    PubMed     Abstract available


  104. DIBLEY L, Khoshaba B, Artom M, Van Loo V, et al
    Patient Strategies for Managing the Vicious Cycle of Fatigue, Pain and Urgency in Inflammatory Bowel Disease: Impact, Planning and Support.
    Dig Dis Sci. 2020 Nov 8. pii: 10.1007/s10620-020-06698.
    PubMed     Abstract available


  105. AXELRAD JE, Sauk JS
    Gastrointestinal Infections in IBD Flares: Can PCR-Based Stool Tests Differentiate the Smoke from the Fire?
    Dig Dis Sci. 2020;65:3064-3065.
    PubMed    


  106. PASTORELLI L, Bezzio C, Saibeni S
    Hold the Foam: Why Topical Budesonide Remains Relevant for IBD Therapy.
    Dig Dis Sci. 2020;65:3066-3068.
    PubMed    


  107. SINGH M, Singh V, Schurman JV, Friesen CA, et al
    Mucosal Th17 Cells Are Increased in Pediatric Functional Dyspepsia Associated with Chronic Gastritis.
    Dig Dis Sci. 2020;65:3184-3190.
    PubMed     Abstract available


    October 2020
  108. HOURI H, Yadegar A, Zali MR
    How Infection with C. difficile Infection Aggravates Inflammatory Bowel Disease: Is It CDI or the CDAI?
    Dig Dis Sci. 2020 Oct 23. pii: 10.1007/s10620-020-06667.
    PubMed    


  109. SCRIBANO ML
    Why Do Immunosuppressed Patients with Inflammatory Bowel Disease Not Seem to Be at a Higher Risk of COVID-19?
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06624.
    PubMed     Abstract available


  110. NGUYEN ALH, Sparrow MP
    Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06662.
    PubMed     Abstract available


  111. KARASKOVA E, Pospisilova D, Velganova-Veghova M, Geryk M, et al
    Importance of Hepcidin in the Etiopathogenesis of Anemia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06652.
    PubMed     Abstract available


  112. VAN GENNEP S, de Boer NKH, Gielen ME, Rietdijk ST, et al
    Impaired Quality of Working Life in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06647.
    PubMed     Abstract available


  113. SITKIN S, Pokrotnieks J
    Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.
    Dig Dis Sci. 2020 Oct 16. pii: 10.1007/s10620-020-06650.
    PubMed     Abstract available


  114. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Correction to: Characterization of Creatine Kinase Levels in TofacitinibTreated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Oct 10. pii: 10.1007/s10620-020-06638.
    PubMed     Abstract available


  115. COSTRINI NV
    Clearing of the Clouds in Inflammatory Bowel Disease Management.
    Dig Dis Sci. 2020 Oct 3. pii: 10.1007/s10620-020-06635.
    PubMed     Abstract available


  116. CAPPELL MS
    Improving the Safety of Endoscopy in Pregnancy: Approaching Gravidity with Gravitas.
    Dig Dis Sci. 2020;65:2745-2748.
    PubMed    


  117. WEINGARDEN AR, Smith P, Streett S, Triadafilopoulos G, et al
    A Failure to Communicate: Disentangling the Causes of Perianal Fistulae in Crohn's Disease and Anal Squamous Cell Cancer.
    Dig Dis Sci. 2020;65:2806-2809.
    PubMed    


    September 2020
  118. SMITH R, Hubers J, Farraye FA, Sampene E, et al
    Accuracy of Self-Reported Vaccination Status in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06631.
    PubMed     Abstract available


  119. XIU MX, Liu YM, Chen GY, Hu C, et al
    Identifying Hub Genes, Key Pathways and Immune Cell Infiltration Characteristics in Pediatric and Adult Ulcerative Colitis by Integrated Bioinformatic Analysis.
    Dig Dis Sci. 2020 Sep 25. pii: 10.1007/s10620-020-06611.
    PubMed     Abstract available


  120. NOMURA E, Sujino T, Hosoe N, Yoshimatsu Y, et al
    Characteristics of the Mucosal Surface on Scanning Electron Microscopy in Patients with Remitting Ulcerative Colitis.
    Dig Dis Sci. 2020 Sep 21. pii: 10.1007/s10620-020-06609.
    PubMed     Abstract available


  121. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    PubMed     Abstract available


  122. BLANEY H, Vu P, Mathew A, Snelling R, et al
    Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06590.
    PubMed     Abstract available


  123. BARSKY M, Meserve J, Le H, Collins A, et al
    Understanding Determinants of Patient Preferences Between Stool Tests and Colonoscopy for the Assessment of Disease Activity in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Sep 1. pii: 10.1007/s10620-020-06568.
    PubMed     Abstract available


  124. BLESL A, Rainer F, Pollheimer M, Kump P, et al
    Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Dig Dis Sci. 2020;65:2730-2734.
    PubMed    


  125. HALLE E, Azahaf M, Duveau N, Lambin T, et al
    Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease.
    Dig Dis Sci. 2020;65:2664-2674.
    PubMed     Abstract available


  126. CERNOCH PS, Fournier N, Zeitz J, Scharl M, et al
    Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study.
    Dig Dis Sci. 2020;65:2654-2663.
    PubMed     Abstract available


    August 2020
  127. MULGUND A, Stein D
    Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year.
    Dig Dis Sci. 2020 Aug 24. pii: 10.1007/s10620-020-06548.
    PubMed    


  128. PANACCIONE R, Isaacs JD, Chen LA, Wang W, et al
    Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06560.
    PubMed     Abstract available


  129. MOKTAN V, Jonica E, Li Z, Hata DJ, et al
    C. difficile and the Patient with Inflammatory Bowel Disease: A Testing Dilemma.
    Dig Dis Sci. 2020 Aug 16. pii: 10.1007/s10620-020-06496.
    PubMed    


  130. LOPEZ RN, Day AS
    The Loneliness of Long-Term Thiopurine Monotherapy for Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Aug 7. pii: 10.1007/s10620-020-06512.
    PubMed    


  131. LAM AY, Gutin LS, Nguyen Y, Velayos FS, et al
    Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2020 Aug 4. pii: 10.1007/s10620-020-06521.
    PubMed    


  132. SCOTT FI
    Infliximab Versus Biosimilars for IBD: Is It Better to Fight Than Switch?
    Dig Dis Sci. 2020;65:2158-2160.
    PubMed    


  133. COATES MD, Seth N, Clarke K, Abdul-Baki H, et al
    Opioid Analgesics Do Not Improve Abdominal Pain or Quality of Life in Crohn's Disease.
    Dig Dis Sci. 2020;65:2379-2387.
    PubMed     Abstract available


    July 2020
  134. PERRY C, Fischer K, Elmoursi A, Kern C, et al
    Vedolizumab Dose Escalation Improves Therapeutic Response in a Subset of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 24. pii: 10.1007/s10620-020-06486.
    PubMed     Abstract available


  135. HIRTEN RP, Stanley S, Danieletto M, Borman Z, et al
    Wearable Devices Are Well Accepted by Patients in the Study and Management of Inflammatory Bowel Disease: A Survey Study.
    Dig Dis Sci. 2020 Jul 23. pii: 10.1007/s10620-020-06493.
    PubMed     Abstract available


  136. XU F, Wheaton AG, Barbour KE, Liu Y, et al
    Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.
    Dig Dis Sci. 2020 Jul 22. pii: 10.1007/s10620-020-06476.
    PubMed     Abstract available


  137. SHARMA S, Weissman S, Mehta TI, Aziz M, et al
    Role of Hospital Teaching Status on Outcomes of Patients with Inflammatory Bowel Disease: A Nationwide Analysis.
    Dig Dis Sci. 2020 Jul 21. pii: 10.1007/s10620-020-06497.
    PubMed     Abstract available


  138. OLAIYA B, Renelus BD, Filon M, Saha S, et al
    Trends in Morbidity and Mortality Following Colectomy Among Patients with Ulcerative Colitis in the Biologic Era (2002-2013): A Study Using the National Inpatient Sample.
    Dig Dis Sci. 2020 Jul 16. pii: 10.1007/s10620-020-06474.
    PubMed     Abstract available


  139. ALGABA A, Guerra I, Ricart E, Iglesias E, et al
    Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06424.
    PubMed     Abstract available


  140. NADPARA N, Reichenbach ZW, Ehrlich AC, Friedenberg F, et al
    Current Status of Medical Therapy for Inflammatory Bowel Disease: The Wealth of Medications.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06471.
    PubMed     Abstract available


  141. GUPTA S, Aihara H, Trivedi HD, Srivastava A, et al
    Heading in the Right Dissection: Toward an Endoscopic Cancer Cure in a Patient with Long-Standing Ulcerative Colitis.
    Dig Dis Sci. 2020 Jul 13. pii: 10.1007/s10620-020-06465.
    PubMed    


  142. REGNER EH, Green AJ, Bain JL, Kattah MG, et al
    Importance of Not MSing Cerebral White Matter Disease in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jul 10. pii: 10.1007/s10620-020-06449.
    PubMed    


  143. KUMAR A, Teslova T, Taub E, Miller JD, et al
    Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06439.
    PubMed     Abstract available


  144. BACH LE, Taleban S
    Vedolizumab (VDZ) for UC and CD: Still Safe and Effective After All These Years.
    Dig Dis Sci. 2020;65:1882-1884.
    PubMed    


  145. RIVIERE P, Laharie D
    Concise Commentary: Spaced Out-Reducing the Relapse Risk in IBD Patients by Lengthening Dosing Intervals of Anti-TNFs.
    Dig Dis Sci. 2020;65:2044-2045.
    PubMed    


  146. CRESPI M, Dulbecco P, De Ceglie A, Conio M, et al
    Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Dig Dis Sci. 2020;65:1904-1916.
    PubMed     Abstract available


  147. REINGLAS J, Gonczi L, Verdon C, Bessissow T, et al
    Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center.
    Dig Dis Sci. 2020;65:2046-2053.
    PubMed     Abstract available


  148. LI J, Liu L, Zhao Q, Chen M, et al
    Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Dig Dis Sci. 2020;65:1971-1979.
    PubMed     Abstract available


    June 2020
  149. STEIN DJ
    All Systems Go: Reconsidering Healthcare Costs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 29. pii: 10.1007/s10620-020-06429.
    PubMed    


  150. FARBER ON, Weingarden A, Lee C, Braxton DR, et al
    Not in the Same Vein: Inflammatory Bowel Disease, Malignancy, and Enterocolic Lymphocytic Phlebitis.
    Dig Dis Sci. 2020 Jun 27. pii: 10.1007/s10620-020-06425.
    PubMed    


  151. BALRAM B, Lubov J, Theoret Y, Afif W, et al
    Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06427.
    PubMed     Abstract available


  152. VISCIDO A, Latella G
    Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of "Non-medical Switch".
    Dig Dis Sci. 2020 Jun 26. pii: 10.1007/s10620-020-06423.
    PubMed    


  153. DIBLEY L, Hart A, Duncan J, Knowles CH, et al
    Clinician Administered and Self-Report Survey Both Effective for Identifying Fecal Incontinence in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 20. pii: 10.1007/s10620-020-06418.
    PubMed     Abstract available


  154. TANDON P, Lee EY, Maxwell C, Hitz L, et al
    Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06381.
    PubMed     Abstract available


  155. DAI C, Jiang M
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jun 11. pii: 10.1007/s10620-020-06313.
    PubMed    


  156. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed    


  157. GADHOK R, Gordon H, Sebepos-Rogers G, Baillie S, et al
    UK Patients of Bangladeshi Descent with Crohn's Disease Respond Less Well to TNF Antagonists Than Caucasian Patients.
    Dig Dis Sci. 2020;65:1790-1799.
    PubMed     Abstract available


  158. MCCURDY JD, Parlow S, Dawkins Y, Samji K, et al
    Tumor Necrosis Factor Inhibitors May Have Limited Efficacy for Complex Perianal Fistulas Without Luminal Crohn's Disease.
    Dig Dis Sci. 2020;65:1784-1789.
    PubMed     Abstract available


    May 2020
  159. CUI Y, Zhang J, Chen Y, Chen LG, et al
    Upregulation of Fecal Epithelial Heparanase mRNA Is Associated with Increased Ulcerative Colitis Activity and Cancerization Risk.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06350.
    PubMed     Abstract available


  160. ZAIDI D, Wine E
    Building Fences: How A20 Protects the Intestinal Mucosa in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:1288-1290.
    PubMed    


  161. LATELLA G, Viscido A
    Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis.
    Dig Dis Sci. 2020;65:1299-1306.
    PubMed     Abstract available


  162. PAINCHART C, Brabant S, Duveau N, Nachury M, et al
    Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.
    Dig Dis Sci. 2020;65:1445-1452.
    PubMed     Abstract available


    April 2020
  163. ROTTENSTREICH A, Shifman Z, Grisaru-Granovksy S, Mishael T, et al
    Factors Associated with Inflammatory Bowel Disease Flare During Pregnancy Among Women with Preconception Remission.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06282.
    PubMed     Abstract available


  164. BARBERIO B, Zingone F, Savarino EV
    Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06268.
    PubMed    


  165. COBURN ES, Siegel CA, Winter M, Shah ED, et al
    Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Dig Dis Sci. 2020 Apr 16. pii: 10.1007/s10620-020-06252.
    PubMed     Abstract available


  166. WATANABE C, Nagahori M, Fujii T, Yokoyama K, et al
    Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
    Dig Dis Sci. 2020 Apr 6. pii: 10.1007/s10620-020-06221.
    PubMed     Abstract available


  167. VAN ERP LW, Roosenboom B, Komdeur P, Dijkstra-Heida W, et al
    Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06222.
    PubMed     Abstract available


  168. CASTANO-RODRIGUEZ N, Paramsothy S, Kaakoush NO
    Promise of Fecal Microbiota Transplantation Therapy in Pouchitis.
    Dig Dis Sci. 2020;65:1107-1110.
    PubMed    


  169. OMORI T, Kambayashi H, Murasugi S, Ito A, et al
    Comparison of Lewis Score and Capsule Endoscopy Crohn's Disease Activity Index in Patients with Crohn's Disease.
    Dig Dis Sci. 2020;65:1180-1188.
    PubMed     Abstract available


  170. WU Y, Ghaly S, Kerr S, Jackson B, et al
    Level of UV Exposure, Skin Type, and Age Are More Important than Thiopurine Use for Keratinocyte Carcinoma Development in IBD Patients.
    Dig Dis Sci. 2020;65:1172-1179.
    PubMed     Abstract available


  171. SONG EM, Lee HS, Kim YJ, Oh EH, et al
    Incidence and Outcomes of Perianal Disease in an Asian Population with Crohn's Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2020;65:1189-1196.
    PubMed     Abstract available


    March 2020
  172. LONGHI MS, Kokkotou E
    Lnc-ing RNA Expression with Disease Pathogenesis: MALAT1 and ANRIL in Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 30. pii: 10.1007/s10620-020-06216.
    PubMed    


  173. LEE JS, Lee HS, Jang BI, Kim ES, et al
    Low Bone Mineral Density in Young Patients Newly Diagnosed with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 28. pii: 10.1007/s10620-020-06220.
    PubMed     Abstract available


  174. HAM NS, Hwang SW, Oh EH, Kim J, et al
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06207.
    PubMed     Abstract available


  175. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed     Abstract available


  176. FRIAS GOMES C, Narula N, Morao B, Nicola P, et al
    Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 21. pii: 10.1007/s10620-020-06204.
    PubMed     Abstract available


  177. XU M, Cen M, Shen Y, Zhu Y, et al
    Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation.
    Dig Dis Sci. 2020 Mar 20. pii: 10.1007/s10620-020-06208.
    PubMed     Abstract available


  178. CONLEY S, Jeon S, Lehner V, Proctor DD, et al
    Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 19. pii: 10.1007/s10620-020-06213.
    PubMed     Abstract available


  179. SYAL G, Robbins L, Kashani A, Bonthala N, et al
    Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06177.
    PubMed     Abstract available


  180. GU P, Yang E, Chittajallu P, McNeill C, et al
    Patient Perception and Clinical Impact of Direct-to-Consumer Advertising in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06180.
    PubMed     Abstract available


  181. JANSSON-KNODELL CL, Harris CE, Loftus EV Jr, Walker RC, et al
    Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06181.
    PubMed     Abstract available


  182. OKA A, Sartor RB
    Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
    Dig Dis Sci. 2020;65:757-788.
    PubMed     Abstract available


    February 2020
  183. KO MS, Rudrapatna VA, Avila P, Mahadevan U, et al
    Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06122.
    PubMed     Abstract available


  184. ZHU M, Xie J
    LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.
    Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06093.
    PubMed     Abstract available


  185. HO SSC, Keenan JI, Day AS
    The Role of Gastrointestinal-Related Fatty Acid-Binding Proteins as Biomarkers in Gastrointestinal Diseases.
    Dig Dis Sci. 2020;65:376-390.
    PubMed     Abstract available


    January 2020
  186. LIMSRIVILAI J, Saleh ZM, Johnson LA, Stidham RW, et al
    Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06071.
    PubMed     Abstract available


  187. LAZARO CM, de Oliveira CC, Gambero A, Rocha T, et al
    Evaluation of Budesonide-Hydroxypropyl-beta-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06075.
    PubMed     Abstract available


  188. BERNARD EJ, Fedorak RN, Jairath V
    Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-019-06036.
    PubMed     Abstract available


  189. GIBSON DJ, Doherty GA
    Fast and Curious: An Algorithmic Approach to Infliximab Dosing in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-020-06084.
    PubMed    


  190. BARRETT KE
    DRAwing Conclusions About the Basis of Diarrhea in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 16. pii: 10.1007/s10620-020-06060.
    PubMed    


  191. STATES V, O'Brien S, Rai JP, Roberts HL, et al
    Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Jan 10. pii: 10.1007/s10620-019-05999.
    PubMed     Abstract available


  192. SATYAM VR, Li PH, Reich J, Qazi T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06016.
    PubMed     Abstract available


  193. DUAN M, Cao L, Gao L, Gong J, et al
    Chyme Reinfusion Is Associated with Lower Rate of Postoperative Ileus in Crohn's Disease Patients After Stoma Closure.
    Dig Dis Sci. 2020;65:243-249.
    PubMed     Abstract available


  194. YANG Z, Bu C, Yuan W, Shen Z, et al
    Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn's Disease.
    Dig Dis Sci. 2020;65:150-157.
    PubMed     Abstract available


    December 2019
  195. TORRES P, Canete F, Nunez L, Aguilar A, et al
    Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06010.
    PubMed     Abstract available


  196. GUBATAN J, Triadafilopoulos G, Fernandez-Becker NQ
    Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Dec 11. pii: 10.1007/s10620-019-05994.
    PubMed    


  197. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Dec 2. pii: 10.1007/s10620-019-05953.
    PubMed     Abstract available


    November 2019
  198. SONNENBERG A, Turner KO, Genta RM
    Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 27. pii: 10.1007/s10620-019-05972.
    PubMed     Abstract available


  199. GU P, Patel D, Lakhoo K, Ko J, et al
    Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05967.
    PubMed     Abstract available


  200. BERTANI L, Bodini G, Mumolo MG, de Bortoli N, et al
    Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05959.
    PubMed     Abstract available


  201. GOVANI SM, Berinstein JA, Waljee AK, Stidham RW, et al
    Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Dig Dis Sci. 2019 Nov 20. pii: 10.1007/s10620-019-05957.
    PubMed     Abstract available


  202. BOSSA F, Biscaglia G, Valvano MR, Costantino G, et al
    Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05904.
    PubMed     Abstract available


  203. KIM J, Feagins LA
    Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05934.
    PubMed     Abstract available


  204. BOPARAI ES, Velayos FS, Roy A, Li C, et al
    Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05931.
    PubMed    


  205. PAI YC, Yu LC
    Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?
    Dig Dis Sci. 2019 Nov 7. pii: 10.1007/s10620-019-05933.
    PubMed    


  206. LEVY AN, Ali N, Andrici J, Hamilton MJ, et al
    It's What's Up Front That Counts-Part Two: Esophageal Crohn's Disease Complicated by Recurrent Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05922.
    PubMed    


  207. JUNG YS, Han M, Park S, Cheon JH, et al
    Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2019 Nov 1. pii: 10.1007/s10620-019-05867.
    PubMed     Abstract available


    October 2019
  208. BERRY SK, Takakura W, Bresee C, Melmed GY, et al
    Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05906.
    PubMed     Abstract available


  209. SINGH SP, Chand HS, Banerjee S, Agarwal H, et al
    Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05838.
    PubMed     Abstract available


    September 2019
  210. LIATSOS C, Papaefthymiou A, Tzouvala M, Doulberis M, et al
    Current Aspects on Differentiating Relapses from Over-Infections in Symptomatic Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:2686-2687.
    PubMed    


  211. PAREDES JM, Moreno N, Latorre P, Ripolles T, et al
    Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:2600-2606.
    PubMed     Abstract available


    August 2019
  212. WATANABE Y, Miyoshi N, Fujino S, Takahashi H, et al
    Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Dig Dis Sci. 2019;64:2280-2285.
    PubMed     Abstract available


    July 2019
  213. WASZCZUK L, Waszczuk K, Waszczuk E
    CT in Crohn's Disease Is Beneficial for Patient Care and Should Not Be Feared.
    Dig Dis Sci. 2019;64:2056-2058.
    PubMed    


  214. CLARK-SNUSTAD KD, Singla A, Lee SD
    Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2019;64:1952-1958.
    PubMed     Abstract available


  215. WEISSHOF R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, et al
    Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Dig Dis Sci. 2019;64:1945-1951.
    PubMed     Abstract available


  216. SCHAD CA, Haac BE, Cross RK, Syed A, et al
    Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:1959-1966.
    PubMed     Abstract available


    June 2019
  217. PAPAMICHAEL K, Cheifetz AS
    Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy.
    Dig Dis Sci. 2019;64:1397-1398.
    PubMed    


  218. ANNESE V
    Biosimilars in IBD: Similarity Breeds Contented Patients.
    Dig Dis Sci. 2019;64:1399-1400.
    PubMed    


  219. YARUR AJ, Bruss A, Naik S, Beniwal-Patel P, et al
    Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:1651-1659.
    PubMed     Abstract available


  220. MARTINEZ MJ, Ripolles T, Paredes JM, Moreno-Osset E, et al
    Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2019;64:1640-1650.
    PubMed     Abstract available


  221. VASUDEVAN A, Raghunath A, Anthony S, Scanlon C, et al
    Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Dig Dis Sci. 2019;64:1622-1631.
    PubMed     Abstract available


  222. PLEVRIS N, Jones GR, Jenkinson PW, Lyons M, et al
    Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
    Dig Dis Sci. 2019;64:1660-1667.
    PubMed     Abstract available


    February 2019
  223. MENG Y, Li Y, Hao R, Li X, et al
    Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05491.
    PubMed     Abstract available


    October 2018
  224. MILLER M, Vu KN, Zemek A, Shelton A, et al
    TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5334.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: